Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

2.
3.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
4.

Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients.

Younes M, Neffati F, Touzi M, Hassen-Zrour S, Fendri Y, Béjia I, Ben Amor A, Bergaoui N, Najjar MF.

Joint Bone Spine. 2007 Oct;74(5):472-6. Epub 2007 Jul 6.

PMID:
17919959
5.

A randomized controlled trial to improve the quality of life of type 2 diabetic patients using a self-help group program.

Chaveepojnkamjorn W, Pichainarong N, Schelp FP, Mahaweerawat U.

Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):169-76.

PMID:
19323050
6.

Type 2 diabetes in primary care in belgium: need for structured shared care.

Goderis G, Borgermans L, Heyrman J, Broeke CV, Grol R, Boland B, Mathieu C.

Exp Clin Endocrinol Diabetes. 2009 Sep;117(8):367-72. doi: 10.1055/s-0028-1103286. Epub 2009 Apr 8.

PMID:
19358093
7.

Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.

Derosa G, Mereu R, Salvadeo SA, D'Angelo A, Ciccarelli L, Piccinni MN, Ferrari I, Gravina A, Maffioli P, Cicero AF.

Intern Med. 2009;48(5):265-71. Epub 2009 Mar 2.

8.

Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.

Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.

Clin Ther. 2008 May;30(5):858-67. doi: 10.1016/j.clinthera.2008.05.004.

PMID:
18555933
9.
10.

Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial.

Schein MH, Gavish B, Baevsky T, Kaufman M, Levine S, Nessing A, Alter A.

J Hum Hypertens. 2009 May;23(5):325-31. doi: 10.1038/jhh.2008.135. Epub 2008 Nov 13.

PMID:
19005477
11.

Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes.

Manaviat MR, Rashidi M, Afkhami-Ardekani M.

Eur J Ophthalmol. 2008 Jul-Aug;18(4):572-7.

PMID:
18609477
12.

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

Beulens JW, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA, Grobbee DE, Stolk RP; AdRem project team; ADVANCE management committee.

Diabetologia. 2009 Oct;52(10):2027-36. doi: 10.1007/s00125-009-1457-x. Epub 2009 Jul 25.

PMID:
19633827
13.

Impact of glitazones on metabolic and haemodynamic parameters in patients with type 2 diabetes mellitus.

Chogtu B, Singh NP, Chawla S, Gupta U.

Singapore Med J. 2009 Apr;50(4):395-9.

14.

Effect of yoga-nidra on blood glucose level in diabetic patients.

Amita S, Prabhakar S, Manoj I, Harminder S, Pavan T.

Indian J Physiol Pharmacol. 2009 Jan-Mar;53(1):97-101.

PMID:
19810584
15.

Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.

DeFronzo RA, Okerson T, Viswanathan P, Guan X, Holcombe JH, MacConell L.

Curr Med Res Opin. 2008 Oct;24(10):2943-52. doi: 10.1185/03007990802418851 . Epub 2008 Sep 10.

PMID:
18786299
16.

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.

Linnebjerg H, Park S, Kothare PA, Trautmann ME, Mace K, Fineman M, Wilding I, Nauck M, Horowitz M.

Regul Pept. 2008 Nov 29;151(1-3):123-9. doi: 10.1016/j.regpep.2008.07.003. Epub 2008 Jul 16.

PMID:
18675854
17.

Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.

Balasubramanian R, Varadharajan S, Kathale A, Nagraj LM, Periyandavar I, Nayak UP, Sharma A, Bolmall C, Baliga VP.

J Indian Med Assoc. 2008 Jul;106(7):464-7.

PMID:
18975505
18.

Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.

Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Cicero AF.

J Clin Pharm Ther. 2009 Feb;34(1):13-23. doi: 10.1111/j.1365-2710.2008.00984.x.

PMID:
19125899
19.

[Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].

Mozdzan M, Ruxer J, Barański M, Roszczyk N, Markuszewski L.

Ann Acad Med Stetin. 2008;54(1):65-9; discussion 69. Polish.

PMID:
19127812
20.

Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.

Yusuff KB, Obe O, Joseph BY.

Pharm World Sci. 2008 Dec;30(6):876-83. doi: 10.1007/s11096-008-9243-2. Epub 2008 Sep 11.

PMID:
18784982

Supplemental Content

Support Center